Capital International Sarl Vertex Pharmaceuticals Inc Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital International Sarl holds 143,048 shares of VRTX stock, worth $56.8 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

143,048

Previous 124,080 15.29%

Holding current value

$56.8 Million

Previous $58.2 Million 14.39%

% of portfolio

1.79%

Previous 1.85%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $8.73 Million - $9.59 Million	18,968 Added 15.29%	143,048 $66.5 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $2.99 Million - $3.69 Million	7,602 Added 6.53%	124,080 $58.2 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $9.33 Million - $10.2 Million	22,891 Added 24.46%	116,478 $48.7 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $4.84 Million - $5.8 Million	14,113 Added 17.76%	93,587 $38.1 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $1.96 Million - $2.1 Million	5,799 Added 7.87%	79,474 $27.6 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $4.8 Million - $5.37 Million	15,253 Added 26.11%	73,675 $25.9 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $2.17 Million - $2.47 Million	7,652 Added 15.07%	58,422 $18.4 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $873,568 - $982,764	3,057 Added 6.41%	50,770 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.22 Million - $1.36 Million	4,461 Added 10.31%	47,713 $13.8 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $287,826 - $358,373	1,225 Added 2.91%	43,252 $12.2 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $1 Million - $1.18 Million	-4,528 Reduced 9.73%	42,027 $11 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $6.01 Million - $7.58 Million	33,939 Added 269.02%	46,555 $10.2 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $401,597 - $449,419	-2,214 Reduced 14.93%	12,616 $2.29 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $63,934 - $75,395	341 Added 2.35%	14,830 $2.99 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $77,425 - $90,249	374 Added 2.65%	14,489 $3.11 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $81,354 - $108,503	393 Added 2.86%	14,115 $3.34 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $137,028 - $162,461	536 Added 4.06%	13,722 $3.73 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $546,563 - $717,019	2,424 Added 22.52%	13,186 $3.83 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $636,866 - $790,018	3,188 Added 42.09%	10,762 $2.56 Million
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $1.26 Million - $1.7 Million	7,574 New	7,574 $1.66 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Vertex Pharmaceuticals Inc Transaction History